论文部分内容阅读
维拉帕米缓释剂(VSR)/群多普利(TDP)是一种治疗原发性高血压(EH)的苯烷基胺钙拮抗剂和血管紧张素转化酶 抑制剂(ACEI)的复方制剂。本文参考近期文献就VSR/TDP的药效学、药动学和临床应用等作一综述。
Verapamil Delayed Release (VSR) / Trandolapril (TDP) is a phenylalkamine calcium antagonist and angiotensin converting enzyme inhibitor (ACEI) for the treatment of essential hypertension (EH) compound. This article reviews recent literature on the pharmacodynamics, pharmacokinetics and clinical applications of VSR / TDP.